Xiamei Zhang

Xiamei Zhang

UNVERIFIED PROFILE

Are you Xiamei Zhang?   Register this Author

Register author
Xiamei Zhang

Xiamei Zhang

Publications by authors named "Xiamei Zhang"

Are you Xiamei Zhang?   Register this Author

14Publications

348Reads

23Profile Views

Distinct Transcriptional Programming Drive Response to MAPK Inhibition in -Mutant Melanoma Patient-Derived Xenografts.

Mol Cancer Ther 2019 12 16;18(12):2421-2432. Epub 2019 Sep 16.

Oncology Drug Discovery, Novartis Institutes for BioMedical Research (NIBR), Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-19-0028DOI Listing
December 2019

Improving cellulase production in submerged fermentation by the expression of a Vitreoscilla hemoglobin in Trichoderma reesei.

AMB Express 2017 Nov 15;7(1):203. Epub 2017 Nov 15.

Institute of Microbiology, Chinese Academy of Sciences, No. 1 West Beichen Road, Chaoyang District, Beijing, 100101, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13568-017-0507-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688050PMC
November 2017

IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism.

Cancer Res 2014 Jun 22;74(12):3317-31. Epub 2014 Apr 22.

Authors' Affiliations: Novartis Institutes for Biomedical Research; Koch Institute for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts; Departments of Bioengineering and Pharmacology; and Moores Cancer Center, University of California, San Diego, La Jolla, CaliforniaAuthors' Affiliations: Novartis Institutes for Biomedical Research; Koch Institute for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts; Departments of Bioengineering and Pharmacology; and Moores Cancer Center, University of California, San Diego, La Jolla, California

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-0772-TDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885639PMC
June 2014

Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus.

J Bacteriol 2003 May;185(10):3127-38

Division of Infectious Diseases and Medical Services, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114-2696, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC154082PMC
http://dx.doi.org/10.1128/jb.185.10.3127-3138.2003DOI Listing
May 2003

Activity of and resistance to moxifloxacin in Staphylococcus aureus.

Antimicrob Agents Chemother 2003 Apr;47(4):1410-5

Division of Infectious Diseases and Medical Services, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114-2696, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC152517PMC
http://dx.doi.org/10.1128/aac.47.4.1410-1415.2003DOI Listing
April 2003

Topoisomerase targeting with and resistance to gemifloxacin in Staphylococcus aureus.

Antimicrob Agents Chemother 2003 Jan;47(1):274-82

Division of Infectious Diseases and Medical Services, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114-2696, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC149033PMC
http://dx.doi.org/10.1128/aac.47.1.274-282.2003DOI Listing
January 2003

Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone.

Antimicrob Agents Chemother 2002 Nov;46(11):3370-80

Division of Infectious Disease and Medical Services, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114-2696, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC128724PMC
http://dx.doi.org/10.1128/aac.46.11.3370-3380.2002DOI Listing
November 2002